Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Boston Scientific (NY:BSX)

92.08 -0.50 (-0.54%)
Streaming Delayed Price Updated: 1:30 PM EST, Dec 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Boston Scientific

< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
News headline image
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Stay informed about the performance of the S&P500 index in the middle of the day on Monday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
News headline image
These S&P500 stocks are gapping in today's session ↗
Stay tuned for the market movements in the S&P500 index on Monday. Check out the gap up and gap down stocks in the S&P500 index during today's session. 
Via Chartmill
News headline image
Q3 Earnings Roundup: Boston Scientific (NYSE:BSX) And The Rest Of The Medical Devices & Supplies - Diversified Segment
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Boston Scientific (NYSE:BSX) and the best... 
Via StockStory
News headline image
UBS Raises Medtronic Target Price Amid Strong Q2, PFA Technology Shines, But "Neutral" Stance Lingers
New York, NY – November 20, 2025 – UBS Group has adjusted its outlook on Medtronic plc (NYSE: MDT) stock, raising its price target to $102.00 from $95.00. This upward revision follows Medtronic's... 
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
$100 Invested In Boston Scientific 15 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
2 Reasons to Watch BSX and 1 to Stay Cautious
Boston Scientific has been treading water for the past six months, recording a small loss of 3.5% while holding steady at $102.88. The stock also fell short of the S&P 500’s 13% gain during that... 
Via StockStory
Topics Stocks
News headline image
3 Market-Beating Stocks with Solid Fundamentals
The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta year in and year out often become the legends... 
Via StockStory
News headline image
1 High-Flying Stock with Promising Prospects and 2 That Underwhelm
"You get what you pay for" often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated... 
Via StockStory
News headline image
1 of Wall Street’s Favorite Stock on Our Watchlist and 2 We Ignore
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional... 
Via StockStory
Topics Electric Vehicles
News headline image
A Look Into Boston Scientific Inc's Price Over Earnings ↗
 
Via Benzinga
News headline image
Boston Scientific Corp (NYSE:BSX) Shows Strong Growth and Bullish Technical Setup ↗
Discover Boston Scientific (BSX), a top growth stock with strong earnings, revenue acceleration, and a bullish technical setup signaling a potential price surge. 
Via Chartmill
News headline image
1 Safe-and-Steady Stock to Keep an Eye On and 2 We Question
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere. 
Via StockStory
News headline image
2 Large-Cap Stocks Worth Investigating and 1 That Underwhelm
Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for... 
Via StockStory
News headline image
5 Insightful Analyst Questions From Boston Scientific’s Q3 Earnings Call
Boston Scientific’s third quarter saw a positive market reaction, reflecting operational execution across multiple business units. Management attributed the strong results to broad-based growth,... 
Via StockStory
Topics Earnings
News headline image
Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 10 Years ↗
 
Via Benzinga
News headline image
Integer Holdings (ITGR) Shares Plunge 31.4% as Slower New Product Adoption and Revised Guidance Rock Investor Confidence
New York, NY – October 23, 2025 – Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract manufacturer, experienced a dramatic downturn in its stock performance today, with shares... 
Via MarketMinute
Topics Earnings Supply Chain
News headline image
What the Options Market Tells Us About Boston Scientific ↗
 
Via Benzinga
News headline image
BSX Q3 Deep Dive: WATCHMAN and Electrophysiology Drive Outperformance, Guidance Raised
Medical device company Boston Scientific (NYSE:BSX) announced better-than-expected revenue in Q3 CY2025, with sales up 20.3% year on year to $5.07 billion. Guidance for next quarter’s revenue was... 
Via StockStory
Topics World Trade
News headline image
These Analysts Increase Their Forecasts On Boston Scientific After Upbeat Earnings ↗
 
Via Benzinga
News headline image
Top S&P500 movers in Wednesday's session ↗
Curious about the S&P500 stocks that are in motion on Wednesday? Join us as we explore the top movers within the S&P500 index during today's session. 
Via Chartmill
News headline image
What's going on in today's session: S&P500 movers ↗
Curious about the top performers within the S&P500 index in the middle of the day on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview. 
Via Chartmill
News headline image
Boston Scientific Gains Momentum As Growth Broadens, Goldman Sachs Says ↗
Goldman Sachs analyst David Roman reiterated a Buy rating and $120 price target for Boston Scientific after strong Q3 results and raised guidance. 
Via Benzinga
News headline image
Tech Stocks Drop, Netflix Sinks 10% On Worst Day Since 2022: What's Moving Markets Wednesday? ↗
Risk sentiment deteriorated sharply on Wednesday as a wave of disappointing earnings guidance and escalating U.S.-China trade tensions rattled investor confidence. 
Via Benzinga
Topics World Trade
News headline image
Boston Scientific (BSX) Stock Is Up, What You Need To Know
Shares of medical device company Boston Scientific (NYSE:BSX) jumped 4.4% in the morning session after the company reported strong third-quarter results that topped Wall Street's forecasts and raised... 
Via StockStory
Topics Artificial Intelligence
News headline image
Boston Scientific Jumps On Strong Guidance, Heart Devices Fuel Topline Growth ↗
Boston Scientific Q3 revenue hit $5.07 billion, beating forecasts. The company raised its full-year guidance based on strong segment growth. 
Via Benzinga
News headline image
Boston Scientific Soars: Q3 2025 Earnings Beat Ignites Medical Device Market
Boston Scientific (NYSE: BSX) has delivered an exceptional third-quarter 2025 earnings report, significantly surpassing analyst expectations and reinforcing its position as a leading innovator in the... 
Via MarketMinute
Topics Artificial Intelligence Earnings Economy
News headline image
Boston Scientific Jumps On Third-Quarter Beat, Strong Guide ↗
Boston Scientific stock jumped early Wednesday on a strong 2025 outlook following its third-quarter sales and earnings beat. 
Via Investor's Business Daily
News headline image
Boston Scientific Corp (NYSE:BSX) Reports Strong Q3 2025 Earnings, Beats Estimates ↗
Boston Scientific beats Q3 2025 earnings and revenue forecasts, reporting strong sales growth and issuing optimistic Q4 guidance. 
Via Chartmill
Topics Earnings
News headline image
Beware The Death Cross: 3 Stocks Triggering This Spooky Signal ↗
The Death Cross is something you never want to see on a stock you own. Take caution with these three companies that recently were visited by this scary signal. 
Via MarketBeat
Topics ETFs
News headline image
Boston Scientific’s (NYSE:BSX) Q3 Sales Top Estimates
Medical device company Boston Scientific (NYSE:BSX) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 20.3% year on year to $5.07 billion. Guidance for next quarter’s... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.